Non-Hodgkin lymphoma Clinical Trials
Recruiting non-hodgkin lymphoma studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat non-hodgkin lymphoma. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting non-hodgkin lymphoma studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting non-hodgkin lymphoma trials
Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies
Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT
GLORY: Glofit-GemOx With Liso-Cel For Lymphoma
Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Hematologic Malignancies
The CARDIOPROTECT Trial
Rutgers University Study of the Genetics of Blood Cancers
Sotagliflozin as Prevention of Anthracycline-Related Cardiotoxicity
Disease Evolution and Risk Factors of AIDS-related Prevalent Cancers
Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers
A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship
More Than Just X-Rays - Imaging of Chemotherapy-induced Morphological and Functional Cardiovascular and Lung Changes After Childhood ALL and Other Cancers - a Monocentric Late Effects Study (MaximALL)
Dexamethasone, Intravenous Injection of Human Immunoglobulin, and Increased Infusion of Mononuclear Cells to Reduce Donor Specific Antibodies in Haploidentical Hematopoietic Stem Cell Transplantation
Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors
CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors
eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation
A Phase Ⅰ Study of CS08399 in Participants With MTAP-deleted Solid Tumors and Lymphoma
Identification of the Best Treatment Pathway for Patients With Relapsed/Refractory Lymphocytic B-derived Non-Hodgkin Lymphoma
Pre-malignant States to Hematologic Malignancies in Firefighters
A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21)
A Study to Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHL
Venetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And T-cell Acute Lymphoblastic Lymphoma
CD19/BAFF-R in Vivo CAR-T Cell Therapy Targeting Relapsed/Refractory B Cell Acute Leukemia/Malignant Lymphoma
Digitalized Exercise Fit Tool Intervention for Adolescents With Blood Cancer
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
Virus-associated Tumour Microenvironment
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
TPG: Tafasitamab, Polatuzumab Vedotin, and Glofitamab as First-line Therapy for Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma
Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
Clonal Hematopoiesis of Immunological Significance
GB5005 CART-cell Injection in the Treatment of Patients With CD19-positive RR B-NHL
Cord Blood Transplantation in Children and Young Adults With Blood Cancer
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
Remote Monitoring and Symptom Management Digital Application
Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma
Halt Aging in Survivors of Blood Cancers
Precision Physical Exercise for Personalized Onco-Hematology.
PIC1 Injection Therapy for Relapsed/Refractory B-NHL
HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors
CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL
Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies
Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
SB-4826 in Adult Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphomas
AI-based Predictive and Interventional System for Early Detection of Non-compliance Risks With Oral Therapies in Lymphoma Patients.
Rituximab Plus Venetoclax in Front Line Marginal Zone Lymphoma
Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
A Study of JNJ-95566692 in Participants With Non-Hodgkin Lymphoid Malignancies
A Phase I Study of JLM019 Injection
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
PET-CT in Lymphoma Among the Eldery
CD19/CD22 CAR-T as First-line Consolidation in Follicular Lymphoma
GSL Synthetase Inhibitor Eliglustat Combined With CD30 Target Immunotherapy for the Treatment of of CD30+ Lymphoma
An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
A Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic Malignancies
Shanghai Lymphoma Clinical Cohort
Amping up With PemJAK
Clinical Study of LV009 Injection for the Treatment of Hematologic and Lymphoid Malignancies
Non-Hodgkin lymphoma clinical trials — common questions
Are non-hodgkin lymphoma clinical trials free to join?
Yes. Participating in a non-hodgkin lymphoma clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a non-hodgkin lymphoma clinical trial?
Each non-hodgkin lymphoma study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a non-hodgkin lymphoma trial near me?
Use the location controls above. We'll show recruiting non-hodgkin lymphoma trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many non-hodgkin lymphoma trials are recruiting right now?
We're currently tracking roughly 143 recruiting non-hodgkin lymphoma trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.